These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4017162)

  • 21. [Tissue concentration of intravesically instilled (2"R)-4'-o-tetrahydropyranyl-adriamycin or adriamycin in superficial bladder cancer].
    Saika T; Tsushima T; Nasu Y; Noda M; Akebi N; Kaku S; Takamatsu M; Ohmori H; Uno S; Johsen T
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1206-10. PubMed ID: 8355436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of 4'-0-tetrahydropyranyladriamycin hydrochloride (THP-ADM) in a human tumor cloning system.
    Inoue K; Arakawa M; Miyamoto H; Ogawa M
    Invest New Drugs; 1983; 1(4):271-5. PubMed ID: 6687222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.
    Camaggi CM; Comparsi R; Strocchi E; Testoni F; Angelelli B; Pannuti F
    Cancer Chemother Pharmacol; 1988; 21(3):221-8. PubMed ID: 3162849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I clinical trial and pharmacokinetic evaluation of 4'-0-tetrahydropyranyladriamycin (THP-adriamycin).
    Raber MN; Newman RA; Lu K; Legha S; Gorski C; Benjamin RS; Krakoff IH
    Cancer Chemother Pharmacol; 1989; 23(5):311-5. PubMed ID: 2706737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity and metabolism of a new anthracycline-containing fluorine (ME2303) in Lewis lung carcinoma-bearing mice.
    Iigo M; Hoshi A; Kadosawa H; Fujigaki M
    Jpn J Cancer Res; 1991 Nov; 82(11):1317-21. PubMed ID: 1752788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilary disposition of adriamycin.
    Riggs CE; Benjamin RS; Serpick AA; Bachur NR
    Clin Pharmacol Ther; 1977 Aug; 22(2):234-41. PubMed ID: 884924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and antitumour activity of a new anthracycline, DA-125, after intravenous administration to subcutaneously implanted Lewis-lung-carcinoma-bearing mice.
    Lee SD; Park JB; Lee WI; Shim HJ; Lee ED; Lee JJ; Kim WB; Yang J; Kim CK; Lee MG
    Biopharm Drug Dispos; 1995 Aug; 16(6):489-505. PubMed ID: 7579031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A study on the correlation between the concentration of antitumor agent and the clinical effect. An experience with THP-ADM].
    Ogawa A; Yamashita K
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):303-8. PubMed ID: 3970553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tissue concentration of 4'-O-tetrahydropyranyladriamycin in renal cell carcinoma and urinary bladder tumor].
    Masuda H; Hirose J; Ohtawara Y; Suzuki K; Tajima A; Aso Y; Shomura T; Kawamura K
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1975-9. PubMed ID: 4051513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A randomized study of pirarubicin (THP) versus adriamycin (ADM) for intravesical instillation therapy against superficial bladder cancer].
    Kawamura J; Tochigi H; Obata K; Ueda K; Otaguro K; Kuriyama M; Shinoda M; Naruse K; Murase T; Hasegawa Y
    Hinyokika Kiyo; 1992 Mar; 38(3):379-85. PubMed ID: 1523998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intravesical chemotherapy of (2''R)-4'-O-tetrahydropyranyladriamycin in bladder tumor].
    Masuda H; Hirose J; Suzuki K; Tajima A; Aso Y
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2411-4. PubMed ID: 3729494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.
    Greene RF; Collins JM; Jenkins JF; Speyer JL; Myers CE
    Cancer Res; 1983 Jul; 43(7):3417-21. PubMed ID: 6850648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pharmacokinetics of KRN8602, a new morpholino anthracycline, and adriamycin in tumor-bearing mice.
    Shinkai H; Takahashi H; Miyamoto K; Uchida T; Tokiwa T
    Cancer Chemother Pharmacol; 1996; 38(5):417-24. PubMed ID: 8765434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
    Hisamatsu T; Suzuki K; Sakakibara S; Komuro K; Nagasawa M; Takeuchi T; Umezawa H
    Jpn J Cancer Res; 1985 Oct; 76(10):1008-20. PubMed ID: 3935619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activities of (2"R)-4'-O-tetrahydropyranyl-adriamycin (THP) and its combination with other antitumor agents on murine tumors.
    Matsushita Y; Kumagai H; Yoshimoto A; Tone H; Ishikura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Oct; 38(10):1408-19. PubMed ID: 4066493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between the intracellular level and growth inhibition of a new anthracycline 4'O-tetrahydropyranyl-Adriamycin in Friend leukemia cell variants.
    Munck JN; Fourcade A; Bennoun M; Tapiero H
    Leuk Res; 1985; 9(2):289-96. PubMed ID: 3990336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antitumor activity of 4'-O-tetrahydropyranyladriamycin on human gastric cancer cells.
    Yamaue H; Tanimura H; Noguchi K; Shono Y; Iwahashi M; Hotta T; Tani M; Tsunoda T; Nishimoto N; Terasawa H; Nakamori M
    Anticancer Res; 1996; 16(1):243-6. PubMed ID: 8615614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative investigation on use of (2''R)-4'-O-tetrahydropyranyl-adriamycin and adriamycin as intravesical chemotherapy for superficial bladder tumors.
    Akaza H; Niijima T; Hisamatsu T; Fujigaki M
    Urology; 1988 Aug; 32(2):141-5. PubMed ID: 3400139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of 4'-deoxy-4'-iodo-doxorubicin in plasma and tissues of tumor-bearing mice compared with doxorubicin.
    Formelli F; Carsana R; Pollini C
    Cancer Res; 1987 Oct; 47(20):5401-6. PubMed ID: 3652044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition and metabolism of adriamycin octanoylhydrazone (NSC 233853) in mice and rabbits.
    Egorin MJ; Clawson RE; Ross LA; Chou FT; Andrews PA; Bachur NR
    Drug Metab Dispos; 1981; 9(3):240-5. PubMed ID: 6113933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.